Señales en vivo de CLRB | Maximiza tus Ganancias con Getagraph.com

VENDER 121839 min ago

@ $3.47

Emitido: 13 feb 2024 @ 11:14

Retorno: -5.18%

Señal anterior: feb 7 - 09:31

Señal anterior: Comprar

Retorno: -0.86 %

Live Chart Being Loaded With Signals

Commentary (7 may 2024 @ 16:00):

Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer...

Stats
Volumen de hoy	738 825
Volumen promedio	990 318
Capitalización de mercado	117.94M
EPS	$-0.610 ( 2024-05-02 )
Próxima fecha de ganancias	( $0 ) 2024-06-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.060
ATR14	$0.00400 (0.12%)

Insider Trading

Date	Person	Action	Amount	type
2023-06-23	Lea Darrell Shane	Buy	100 000	Stock option (right to buy)
2023-12-08	Lea Darrell Shane	Buy	39 599	Common Stock
2023-06-23	Kolean Chad J	Buy	104 000	Stock option (right to buy)
2023-12-08	Kolean Chad J	Buy	42 554	Common Stock
2023-12-08	Shustov Andrei	Buy	47 856	Common Stock

INSIDER POWER
100.00
Last 93 transactions
Buy: 8 845 700 \| Sell: 235 734

Volumen Correlación

Largo: -0.04 (neutral)

Corto: -0.06 (neutral)

Signal:(58.011) Neutral

Cellectar Biosciences Inc Correlación

10 Correlaciones Más Positivas
REGN	0.88
CNTX	0.857
AIP	0.849
AMWD	0.841
PLAB	0.841
FTAIO	0.839
LBPH	0.835
RBKB	0.833
AMTX	0.832
RCMT	0.831

10 Correlaciones Más Negativas
AMRB	-0.847
SALM	-0.84
OSMT	-0.822
NVEI	-0.809
MLVF	-0.807
GHVI	-0.806
GOODM	-0.806

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cellectar Biosciences Inc Correlación - Moneda/Commodity

0.65
( weak )

0.83
( strong )

0.00
( neutral )

0.85
( strong )

0.00
( neutral )

0.12
( neutral )

Cellectar Biosciences Inc Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$-192 375 (0.00 %)
EPS:	$-3.11

FY	2023
Ingresos:	$0
Beneficio Bruto:	$-192 375 (0.00 %)
EPS:	$-3.11

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-238 867 (0.00 %)
EPS:	$-4.05

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-4.30

Financial Reports:

No articles found.

Cellectar Biosciences Inc

Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients; and Phase I study for various pediatric cancers, r/r head and neck cancers, and R/R MM. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative PDC programs with Avicenna Oncology GMBH to develop CLR 2000 Series; Orano Med to develop CLR 12120 Series; IntoCell Inc; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey.